Navigation Links
Lung Cancer Asbestos Victims Center Now Urges Family Members Of All Lung Cancer Victims To Call Them If The Loved One Was Exposed To Asbestos At Work-Major Compensation
Date:2/14/2013

(PRWEB) February 14, 2013

The Lung Cancer Asbestos Victims Center is now urging family members, loved ones, or friends of lung cancer victims to ask the loved one if he or she had long term exposure to asbestos at their workplace. The group needs the help of family members, friends, and loved ones because they are certain the vast majority of lung cancer victims are unaware there could be significant financial compensation for exposure to asbestos at the workplace. According to the American Lung Association, "Nonsmoking asbes­tos workers are five times more likely to develop lung cancer than non­smokers not ex­posed to asbestos. The majority of living lung cancer patients have been diagnosed within the last five years. Lung cancer is mostly a disease of the elderly. In 2006, 81 percent of those living with lung cancer were 60 years of age or older." The Lung Cancer Asbestos Victims Center says, "There are currently about 374,000 US citizens living with lung cancer. Of this group we are certain at least 10% were exposed to asbestos at their place of work. We need family members, or loved ones to help us get these victims identified for possible compensation in the tens of thousands, or more." If a victim of any type of lung cancer had long term exposure to asbestos in their workplace, the Lung Cancer Asbestos Victims Center will direct the victim, or family members to a very capable law firm that has an established record of achieving superior results for their clients. For more information, lung cancer victims or their family members are urged to call the Lung Cancer Asbestos Victims Center at 866-714-6466. http://LungCancerAsbestosVictimsCenter.Com

Important Note From The Lung Cancer Asbestos Victims Center: "As long as it has been less that two years after the death of a loved one to lung cancer, there still may be significant financial compensation for the family members, but we need to be able to prove the victim was exposed to asbestos at their workplace." http://LungCancerAsbestosVictimsCenter.Com

The Lung Cancer Asbestos Victims Center says, "US Navy Veterans have the highest incidence of exposure to asbestos. Other high risk workplaces for asbestos exposure include current, or former shipyards in California, Virginia, Washington, Texas, Louisiana, Pennsylvania, or Maine, power plants, manufacturing factories, chemical plants, oil refineries, mines, smelters, aerospace manufacturing facilities, demolition construction work sites, railroads, automotive manufacturing facilities, or auto brake shops. As long as the victim, or their family members can prove the exposure to asbestos, we will do everything possible to help them get what might be significant financial compensation." For more information lung cancer victims or their family members are urged to call the Lung Cancer Asbestos Victims Center at 866-714-6466. http://LungCancerAsbestosVictimsCenter.Com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10414513.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Copper depletion therapy keeps high-risk triple-negative breast cancer at bay
2. Key molecule suppresses growth of cancerous liver tumors, Mayo study finds
3. Protein central to cancer stem cell formation provides new potential target
4. Tube versus IV feeding in malnourished pediatric cancer patients
5. Could Duration of Prostate Cancer Hormone Therapy Be Halved?
6. Researchers discover biological diversity in triple-negative breast cancer
7. Additional noteworthy research to be presented at the 2013 Genitourinary Cancers Symposium
8. Emerging cancer drugs may drive bone tumors
9. Lung cancer set to overtake breast cancer as the main cause of cancer deaths among European women
10. Watch and Wait Approach Often Best for Older Patients With Kidney Cancer
11. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... VA (PRWEB) , ... March 27, 2017 , ... ... application containerization, today announced it will co-exhibit with technology partners LG Business Solutions ... at the Marriott Metro Center in Washington D.C., will provide education and examination ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... the CE Certificate of Conformity for the Smart System® 20/20. CE Certification builds ... highest industry standards and specifications such as ANSI, ISO and proven test methods ...
(Date:3/27/2017)... ... 2017 , ... Osteitis pubis may be commonplace and seemingly ... occurs when the muscles around the pelvis become inflamed. Over time, untreated osteitis ... as well as accompanying tenderness and weakness. Without proper intervention, it can hinder ...
(Date:3/27/2017)... ... March 27, 2017 , ... EpiGentek , a Farmingdale, ... recent RNA methylation “gold rush” with their established portfolio of optimized assay kits ... N6-methyladenosine, or m6A , RNA methylation has received a new burst in ...
(Date:3/27/2017)... San Mateo, CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still ... one of the best days I’ve had in a long time,” she said. , She ... a lot of money that I never thought I would have to help my students.” ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology: